Hamill Laura
- SEC CIK
- 0001751804
No open-market purchases or sales filed in the past year.
Current role at each company
- JAZZ Jazz Pharmaceuticals plcDirectoras of Sep 2, 2026
- FATE Fate Therapeutics IncDirectoras of Jun 15, 2026
- YMAB Y-mAbs Therapeutics, Inc.Directoras of Sep 19, 2025
- PRDS Pardes Biosciences, Inc.Directoras of Aug 31, 2023
- SCLX Scilex Holding CoDirectoras of Jan 17, 2023
Show 2 more companies
- ANAB Anaptysbio, IncDirectoras of Jan 10, 2023
- XLRN Acceleron Pharma IncDirectoras of Nov 22, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hamill Laura as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
No insider trades match these filters.